The largest database of trusted experimental protocols

5 protocols using hotstarttaq plus dna polymerase

1

Sequencing of IGFBP7 Exons in Ovarian Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
The genomic DNA for each EOC cell line (OV90, TOV21G, TOV112D, TOV81D, TOV1946, OV1946 and TOV2223) was amplified for each of the five exons of IGFBP7 and flanking introns using previously published primer sets [54 (link)] (Additional file 1). PCR reactions were performed as described above, but using the following PCR thermal cycler conditions for each primer set: 95°C for 3 minutes, 94°C for 30 seconds, 60°C for 30 seconds, 72°C for 30 seconds, and a final extension at 72°C for 5 minutes for 35 cycles. QIAGEN HotStart Taq Plus DNA Polymerase and 5X Q-solution (Cat. No. 203603, QIAGEN Inc. Mississauga, ON, Canada) were used for the amplification of the G-C rich exon 1. PCR products were then subjected to a Sanger sequencing protocol using 3730XL DNA Analyzer systems from Applied Biosystems at the McGill University and Genome Québec Innovation Centre (gqinnovationcenter.com). Sequencing chromatograms were analysed using 4Peaks Version 1.7.2. Sequence alignment was performed using the ClustalW multiple sequence alignment platform from the European Bioinformatics Institute [55 (link)] and compared with NM_001553 (IGFBP7) sequence. Variants identified were compared with those reported in the Single Nucleotide Polymorphism (dbSNP) database (http://www.ncbi.nlm.nih.gov/projects/SNP/).
+ Open protocol
+ Expand
2

IGFBP7 DNA Methylation Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The sodium bisulfite treatment method was used to assess methylation of IGFBP7 using the QIAGEN EpiTect Bisulfite Kit (QIAGEN Inc., Mississauga, ON, Canada) according to the manufacturer’s instructions. Two μg of genomic DNA from each EOC cell line was used for the conversion. Methylation-specific PCR was carried out using previously published primers (Additional file 1) [37 (link)]. PCR amplification of DNA was performed using QIAGEN HotStart Taq Plus DNA Polymerase (QIAGEN Inc. Mississauga, ON, Canada) as described above under the following PCR conditions: with the methylated primers for 35 cycles at 95°C for 5 minutes, 94°C for 30 seconds, 55°C for 30 seconds, 72°C for 30 seconds, and a final extension at 72°C for 5 minutes; and with the unmethylated primers for 35 cycles at 95°C for 5 minutes, 94°C for 30 seconds, 60°C for 30 seconds, 72°C for 30 seconds, and a final extension at 72°C for 5 minutes. The PCR products were resolved in 1% gel electrophoresis.
+ Open protocol
+ Expand
3

Genetic Analysis of F11 Gene Mutations

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA was extracted using standard procedures. The PCR reaction was performed in a total volume of 50 μl containing 100 ng of genomic DNA, 1 U of HotStartTaq Plus DNA Polymerase (QIAGEN, Valencia, CA, USA), 1× PCR Buffer, 1× Q-Solution, 0.2 mm dNTPs, and 0.4 μm of forward and reverse oligonucleotides. A typical PCR cycling protocol was optimized under the following conditions: an initial activation step of 5 min at 95 °C, followed by 35 cycles at 94 °C for 1 min, 63 °C for 55 s, 72 °C for 1 min, and a final extension of 10 min at 72 °C. Direct sequencing of the coding regions, intron–exon boundaries, and 5′ and 3′ non-translated regions of the F11 (GenBank accession number NT_022792) was performed to detect mutations. The sequences were obtained using a BigDyeTerminator v3.1 Cycle Sequencing kit and the ABI PRISM 3130 Genetic Analyzer Sequencer (PE Biosystems, Foster City, CA, USA).
+ Open protocol
+ Expand
4

Gene Expression Regulation in Breast Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dulbecco's minimum essential medium (DMEM), glutamine and penicillin/streptomycin/glutamine stock mix were purchased from Life Technologies, Inc. (Carlsbad, CA, USA). Fetal bovine serum (FBS) and charcoal-stripped FBS were from Invitrogen (Carlsbad, CA, USA). L-trans-Epoxysuccinyl-leucylamido (4-guanidino) butane (E-64) was from Sigma-Aldrich (St. Louis, MO USA). CTSO, MTDH, PABPC4L, LMNA, EEFiA1and control small interfering RNAs (siRNA) were purchased from Dharmacon (Thermo Scientific Dharmacon, Inc.). CTSO plasmid was purchased from OriGene (Rockville, MD, USA). Affinity purified rabbit and mouse antibodies against human BRCA1 and CTSO were from Santa Cruz Biotechnologies (Santa Cruz, CA, USA). ZNF423 antibody was purchased from Abcam (Cambridge, MA, USA). Actin, MTDH, PABPC4L, LMNA, and EEFiA1 antibodies were from cell signaling (Danvers, MA, USA). For standard PCR, HotStart Taq Plus DNA Polymerase was used (Qiagen, Germantown, MD, USA). Reagents and primers for real time PCR were purchased from Qiagen (Valencia, CA, USA). The protease inhibitor cocktail kit was obtained from Pierce Biotechnology (Rockford, IL, USA). 17β-estradiol (E2) and 4-hydroxytamoxifen (OH-TAM) were purchased from Sigma Aldrich (Saint Louis, MO USA). Olaparib was from Selleckchem (Houston, TX, USA).
+ Open protocol
+ Expand
5

Sanger Sequencing of Candidate Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
Given the expense of WGS, we used Sanger sequencing to provide genotypes in individuals in local family AU071 for the small number of candidate risk variants. Genomic DNA was PCR amplified using customized primers designed by the online tool Primer3Plus(Untergasser et al. 2007 (link)) with HotStartTaq Plus DNA Polymerase (QIAGEN) with annealing temperatures of 58C. GenScript Biotech (Piscataway, NJ) performed Sanger sequencing. Biosamples are not available for individuals in the MSSNG database, so there was no opportunity to validate variants in them. The study involving AU071 was approved by the University of Washington Institutional Review Board, and informed consent was obtained from all participants or their parents.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!